Clinical Trial Update: A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pegylated interferon lambda monotherapy for chronic hepatitis delta virus; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis D

Drugs mentioned

• Pegylated Interferon Lambda (pegylated interferon lambda-1a)

Snippet

Sponsor: Eiger BioPharmaceuticals | Conditions: Hepatitis D, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2023-01-17